Clinical Trials Directory

Trials / Completed

CompletedNCT06240585

Gastroparesis as an Early Sign of Sepsis

Status
Completed
Phase
Study type
Observational
Enrollment
260 (actual)
Sponsor
Meir Medical Center · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Upper gastrointestinal tract disorders, such as gastroparesis, are common in critically ill patients in the ICU, estimated at 60%. Gastroparesis symptoms include nausea, vomiting and abdominal pain. Risk factors for the development of gastroparesis include diabetes, surgical injury to the vagus nerve (such as certain types of bariatric surgery, and in the past - surgeries for patients who suffered from peptic ulcer), use of drugs that inhibit the activity of the digestive system such as opiates, anticholinergic drugs, sepsis, as well as being bedridden and inactive - are all common conditions in critically ill patients. There are different definitions for gastroparesis. One of the accepted definitions refers to gastric residual volume (GRV) over 200 ml at one measurement. Gastroparesis is found in some studies to be associated with increased morbidity and mortality in critically ill patients. As mentioned above, it is known that sepsis is a risk factor for gastroparesis. According to our experience based on treatment of a large number of septic patients, we have the impression that often gastroparesis is an early sign for the development of sepsis. We did not find any studies that tested this hypothesis. In this study we would like to investigate whether the development of gastroparesis in critical patients in intensive care can be a predictive sign for the development of sepsis.

Conditions

Interventions

TypeNameDescription
OTHERpresence of gastroparesis as an early sign for sepsis (bacteremia)- measurement of gastric residual volumepresence of gastroparesis as an early sign for sepsis (bacteremia)-measurement of gastric residual volume

Timeline

Start date
2024-06-01
Primary completion
2025-05-01
Completion
2025-05-01
First posted
2024-02-05
Last updated
2025-05-13

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT06240585. Inclusion in this directory is not an endorsement.